newsfilter
← Latest News
Business Wire·

ImmunityBio Appoints Dr. Jim Yong Kim, Former World Bank President and Global Health Leader, as Vice Chairman

IBRX
  • ImmunityBio, Inc. announced that Dr. Jim Yong Kim has joined as Vice Chairman to lead the newly formed Office of the Executive Chairman.
  • Dr. Kim will report to Executive Chairman Dr. Patrick Soon-Shiong & focus on strengthening international partnerships, global relationships, & access to therapies outside the United States.
  • The new office will unite senior leaders to support strategy, partnerships, & initiatives designed to advance ImmunityBio's scientific & clinical programs globally.
  • Dr. Kim brings decades of leadership experience including serving as the 12th president of the World Bank Group from 2012 to 2019.
  • He previously co-founded Partners In Health in 1987 & led the World Health Organization's HIV/AIDS department from 2003 to 2005.
  • His career includes roles as president of Dartmouth College, professorships at Harvard, & current positions as Vice Chairman at Global Infrastructure Partners & Chancellor of the University of Global Health Equity in Rwanda.
  • Dr. Soon-Shiong stated that Dr. Kim's background in global health & development finance will be invaluable for building partnerships to accelerate research & expand access.
  • ImmunityBio is a commercial-stage immunotherapy company focused on the Cancer BioShield platform & its proprietary ANKTIVA receptor agonist.
  • The press release includes forward-looking statements regarding clinical development, regulatory pathways, & potential risks associated with the company's operations.